309 related articles for article (PubMed ID: 11267975)
1. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.
Tumber A; Morgan HM; Meikle MC; Hill PA
Int J Cancer; 2001 Mar; 91(5):665-72. PubMed ID: 11267975
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
3. Effects of experimental conditions on the release of 45calcium from prelabeled fetal mouse long bones.
van Beek E; Oostendorp-van de Ruit M; van der Wee-Pals L; Bloys H; van de Bent C; Papapoulos S; Löwik C
Bone; 1995 Jul; 17(1):63-9. PubMed ID: 7577160
[TBL] [Abstract][Full Text] [Related]
4. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
6. The effects of serine proteinase inhibitors on bone resorption in vitro.
Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA
J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.
Blavier L; Delaissé JM
J Cell Sci; 1995 Dec; 108 ( Pt 12)():3649-59. PubMed ID: 8719871
[TBL] [Abstract][Full Text] [Related]
8. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
9. Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones.
Leloup G; Delaisse JM; Vaes G
J Bone Miner Res; 1994 Jun; 9(6):891-902. PubMed ID: 8079664
[TBL] [Abstract][Full Text] [Related]
10. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
11. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.
Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956
[TBL] [Abstract][Full Text] [Related]
13. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
14. Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha.
Fried RM; Voelkel EF; Rice RH; Levine L; Gaffney EV; Tashjian AH
Endocrinology; 1989 Aug; 125(2):742-51. PubMed ID: 2546747
[TBL] [Abstract][Full Text] [Related]
15. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
Lorenzo JA; Raisz LG; Hock JM
J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
[TBL] [Abstract][Full Text] [Related]
16. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
17. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
18. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
Nakamura H; Hiraga T; Ninomiya T; Hosoya A; Fujisaki N; Yoneda T; Ozawa H
J Bone Miner Metab; 2008; 26(6):642-7. PubMed ID: 18979165
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.
Löwik CW; van der Pluijm G; Bloys H; Hoekman K; Bijvoet OL; Aarden LA; Papapoulos SE
Biochem Biophys Res Commun; 1989 Aug; 162(3):1546-52. PubMed ID: 2548501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]